Resmed Inc. buy Royal Bank of Canada
Start price
31.10.25
/
50%
€212.60
Target price
31.10.26
€261.85
Performance (%)
-15.29%
Price
22:25
€180.10
Summary
This prediction is currently active. The price of Resmed Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -15.29%. This prediction currently runs until 31.10.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Resmed Inc. | 12.903% | 12.903% |
| iShares Core DAX® | 1,77 % | 3,45 % |
| iShares Nasdaq 100 | -3,50 % | 1,61 % |
| iShares Nikkei 225® | -4,94 % | 4,22 % |
| iShares S&P 500 | 0,30 % | 2,58 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Resmed Inc. diskutieren
ResMed (NYSE:RMD) had its price target raised by analysts at Royal Bank Of Canada from $300.00 to $303.00. They now have an "outperform" rating on the stock.
Ratings data for RMD provided by MarketBeat